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Abstract
Background: Hyperglycemia in hospitalized patients is known to be related to a higher incidence of clinical and 
surgical complications and poorer outcomes. Adequate glycemic control and earlier diagnosis of type 2 diabetes 
during hospitalization are cost-effective measures.
Methods: This prospective cohort study was designed to determine the impact of hyperglycemia on morbidity and 
mortality in a general hospital setting during a 3-month period by reviewing patients' records. The primary purposes of 
this trial were to verify that hyperglycemia was diagnosed properly and sufficiently early and that it was managed 
during the hospital stay; we also aimed to evaluate the relationship between in-hospital hyperglycemia control and 
outcomes such as complications during the hospital stay, extent of hospitalization, frequency of re-hospitalization, 
death rates and number of days in the ICU (Intensive Care Unit) after admission. Statistical analyses utilized the Kruskall-
Wallis complemented by the "a posteriori" d.m.s. test, Spearman correlation and Chi-squared test, with a level of 
significance of 5% (p < 0.05).
Results: We reviewed 779 patient records that fulfilled inclusion criteria. The patients were divided into 5 groups: 
group (1) diabetic with normal glycemic levels according to American Diabetes Association criteria for in-hospital 
patients (n = 123); group (2) diabetics with hyperglycemia (n = 76); group (3) non-diabetics with hyperglycemia (n = 
225); group (4)diabetics and non-diabetics with persistent hyperglycemia during 3 consecutive days (n = 57) and 
group (5) those with normal glucose control (n = 298). Compared to patients in groups 1 and 5, patients in groups 2, 3 
and 4 had significantly higher mortality rates (17.7% vs. 2.8%) and Intensive Care Unit admissions with complications 
(23.3% vs. 4.5%). Patients in group 4 had the longest hospitalizations (mean 15.5 days), and group 5 had the lowest re-
hospitalization rate (mean of 1.28 hospitalizations). Only 184 (51.4%) hyperglycemic patients had received treatment. 
An insulin "sliding-scale" alone was the most frequent treatment used, and there was a wide variation in glucose target 
medical prescriptions. Intra Venous insulin infusion was used in 3.8% of patients in the ICU. Glycohemoglobin(A1C) was 
measured in 11 patients(2.2%).
Conclusions: Hospital hyperglycemia was correlated with, among other parameters, morbidity/mortality, length of 
hospitalization and number of re-hospitalizations. Most patients did not have their glycemic levels measured at the 
hospital; despite the high number of hyperglycemic patients not diagnosed as diabetics, A1C was not frequently 
measured. Even when patients are assessed for hyperglycemia, they were not treated properly.
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Introduction
Hyperglycemia in a hospital, with or without a previous
history of diabetes, setting occurs frequently in patients
with acute myocardial infarction, trauma, burns, cardiac
surgery, stroke and septicemia [1,2].
Most observational and retrospective studies have
reported that hyperglycemia in patients with severe dis-
ease is associated with an increased risk of complications,
longer ICU stay and higher mortality rates [3-6].
The pathophysiological mechanism that might explain
the relationship between increased glycemia and likeli-
hood to develop complications or death in critically ill
patients has not been established. It is controversial
whether the increase in glycemic levels is independently
associated with a worse prognosis or whether it may indi-
cate a more severe disease with a stronger response to
stress [7].
Several randomized prospective studies have shown
that intense control of glycemia reduces multiple organ
failure, infection, mortality both in the short and long
term, and hospitalization and ICU stays, with consequent
lower total hospitalization costs [7-9].
Trials examining the effects of tighter glucose control
have had conflicting results. Systematic reviews and
meta-analyses have also had differing conclusions [10,11].
The purpose of this study was to assess how glycemic
levels are managed in hospitalized patients and the
impact of hyperglycemia on patient outcomes both in the
ward and the ICU of a general hospital.
Methods
A prospective cohort study was conducted with the eval-
uation of all in-patients from the Hospital Cruz Vermelha
Brasileira - Filial do Paraná, admitted between September
4, 2007 and December 4, 2007. The patients were fol-
lowed until discharge. The patients studied were in both
private and public health systems, from wards, private
rooms and from the general and coronary ICUs.
Items evaluated were: patient age and gender, use of
drugs for diabetes treatment, use of medications that
might alter glycemic levels, whether there had been a pre-
vious diabetes diagnosis, reason for hospitalization and
length of hospital stay, concurrent clinical and surgical
conditions, glycated hemoglobin, plasmatic and capillary
glycemia, endocrinologist evaluation, need for re-hospi-
talization, and the definition of cases who were given IV
insulin infusion in the ICU.
Exclusion criteria were: hospital stay shorter than 24
hours, patients who were under 18 years of age and preg-
nant women.
The data were obtained by accessing electronic patient
records, in addition to reading the printed and written
patient records available in files at the nursing stations of
each hospital section. Whenever a record was incom-
plete, additional information was requested directly from
the patient or family members, and they were asked to
sign the Informed Consent Form.
We did not continue to follow the patients who had not
had any glucose tests within 72 hours of admission.
Patients in the general and coronary ICUs were followed
even after discharge from the ICU but were still in the
hospital. We used the reference values for the exams
established by the American Diabetes Association (ADA)
[12]. In-hospital hyperglycemia in the wards was defined
as fasting plasma glucose levels higher than 110 mg/dL
and/or capillary glucose levels higher than 180 mg/dL
a f t e r  e a t i n g  a n d  h i g h e r  t h a n  1 3 0  m g / d L  b e f o r e  m e a l s ;
hyperglycemia in the ICU was defined as glucose levels
higher than 110 mg/dL; in general, hyperglycemia was
defined as higher than 180 mg/dL at both locations. Per-
sistent hyperglycemia was defined as glucose levels
higher than 180 mg/dL one or more times during three
days in the hospital[14]. Controlled glycemia was defined
as no persistent hyperglycemia during the patient's stay
either in the ward or the ICU. Hypoglycemia was defined
as glucose levels lower than 60 mg/dL.
Plasma glucose and glycated hemoglobin tests were
performed by the hospital's laboratory. Plasma glucose
was measured using the Enzymatic/Colorimetric Method
with computerized equipment and a kit from BioTécnica
Indústria e Comércio Ltda. The glycated hemoglobin test
was performed by determining blood glucohemoglobin
levels using the cation exchange method with the Glico-
Teck®  kit (Katal Biotecnológica Indústria e Comércio
Ltda). Capillary glucose measurements were entered into
the printed patient records after having been checked by
the nursing team with the Accu-Check Advantage® device
(Roche). This device satisfied the requirements of rule
98/79/CE regarding products for diagnosis in vitro.
The data were collected daily by five 4th-year Universi-
dade Positivo medical school students, who were trained
by the endocrinologist and diabetes specialist. Prior to
the study, a two-week pilot project was conducted to
ensure the applicability of the chosen methodology and
the correct formulation of the data collection protocols.
This study was approved by the Committee of Univer-
sity Research Ethics of Universidade Positivo and by the
higher management of the Hospital.
Microsoft Excel was used to enter patient records, and
the statistical analysis was performed with Statistic ver-
sion 6.0. First, patients were categorized in groups based
on capillary and lab glucose levels. The groups were com-
pared using the Kruskal-Wallis test. The normal distribu-
tion assumption and the equality of variance were tested
using the Levene's test. To verify the significant differ-
ences among the groups, the "a posteriori" d.m.s. test was
used to supplement the Kruskal-Wallis test. The Spear-
man's coefficient and Chi-squared test were used to eval-Leite et al. Diabetology & Metabolic Syndrome 2010, 2:49
http://www.dmsjournal.com/content/2/1/49
Page 3 of 6
uate the association among some of the variables. The
significance level used in the comparisons was 5%.
Results
Between September and December 2007, 2140 patients
were admitted to the Hospital Cruz Vermelha Brasileira -
Filial do Paraná, a general hospital where most attending
physicians are general practitioners.
We evaluated patients hospitalized both through the
SUS (Public Brazilian Health Care System) and the pri-
vate health care system. Half of the beds were assigned
for surgery and the other half for clinical treatment. The
algorithm for patient inclusion in this study is shown in
Figure 1. A total of 719 patients had their glucose levels
assessed at the time of hospital admission.
Patients whose glucose levels were tested during their
stay or upon admission and/or during hospitalization in
the ICU and/or ward (n = 779) were included in the anal-
ysis. These patients were categorized into five groups
according to their hospital hyperglycemia status. Table 1
shows the patients' demographic information. There were
similar numbers of men and women in the study.
Although 36.2% of the patients (n = 225) had in-hospi-
tal hyperglycemia without a previous diabetes diagnosis,
t h e  A 1 C  t e s t  w a s  a d m i n i s t e r e d  i n  o n l y  2 . 2 %  o f  t h e
patients (n = 11).
Patients with hyperglycemia had significantly longer
hospital stays, regardless of diabetes (Table 2).
Diabetes Mellitus (DM) was the cause of admission for
16 cases, 12 of whom were admitted into the ward and 4
into the ICU; admission for hypoglycemia occurred for
only 1 case. Hypoglycemic events occurred in 18 patients
in the ward and 36 patients in the ICU.
Of the 249 patients who developed hyperglycemia in
the ward, only 106 were treated. Of the treated patients,
34 patients remained on oral agents. Insulin was pre-
scribed to 70% of the patients (n = 74), 75% of whom (n =
54) were treated with sliding-scale insulin alone; 18
patients were treated with basal insulin NPH associated
with sliding-scale regular insulin. In most cases, hyperg-
lycemia was treated when glucose levels were higher than
200 mg/dl.
Medication that interfered in glucose metabolism, such
as corticoid therapy, was used in 49 patients, who then
became hyperglycemic; NPH insulin was given to only 14
of these patients.
In the ICU, patients in groups 2, 3 and 4 (n= 149) had a
significantly higher mortality rate of 16.1% (n = 24) com-
pared to the 2.8% (n = 2) in patients with normal glucose
(n = 71) (p = 0.0001) (Table 3).
Patients with hyperglycemia in the ward (n = 249) were,
significantly more likely to require admission into the
ICU 23.3% (n = 57) compared to 4.5% (n = 11) of those
who were normoglycemic (n = 246) (p = 0.0001)).
In the ICU, 78 of the 149 patients with glucose levels
higher than 180 mg/dL were treated; the sliding scale
insulin alone was used in 86% of the cases. Continuous IV
insulin infusion was administered to 3.8% of the patients.
There is no clear algorithm for making temporary cor-
rective changes to reach and maintain the recommended
blood glucose levels successfully within a pre-specified
target range of glucose levels.
Although a prevalence of in-hospital hyperglycemia
was shown, an endocrinology evaluation was required in
only 4.8% of the cases.
Discussion
In this cohort of patients hospitalized in a community
hospital setting, we demonstrated that hyperglycemia led
to poorer clinical outcomes, with increased morbidity
Figure 1 Total number of patients in-hospital during 3 months 
and inclusion algorithm in the study (Glucose is expressed in mg/
dL).
Table 1: Patient demographics according to glycemic 
status:
Groups  Number of Patients Mean
Ages 
SD %
Group (1) 123 64.7 14.1 15.8
Group (2) 76 63.9 14.4 9.8
Group (3) 225 59.1 19.4 28.9
Group (4) 57 64.1 15.1 7.3
Group (5) 298 53.8 17.3 38.3
TOTAL 779 58.8 17.6 100
Group(1) = DM+ Normal Glucose; Group(2) = DM+ Hyperglycemia; 
Group(3) = Hospital Hyperglycemia; Group(4) = Persistent 
Hyperglycemia; Group(5) = Normal GlycemiaLeite et al. Diabetology & Metabolic Syndrome 2010, 2:49
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and mortality and length of hospital stay. Similar results
had been reported in other studies [1,13,19,21].
Most patients were not checked for glucose levels dur-
ing their stay in the hospital, which shows that the glu-
cose level parameter is not adequately valued as an
impacting factor in the hospital setting.
Because half of the patients were admitted for surgical
reasons and their glucose levels may not have been tested
prior to admission, the number of patients whose glucose
levels were not evaluated may have been overestimated.
It is noteworthy that hyperglycemia was not treated in
57.5% of the patients, probably because treatment was
started only when blood glucose levels were higher than
200 mg/dL, although the recommendations for managing
inpatient hyperglycemia are to target random blood glu-
cose levels lower than 180 mg/dL [22].
In our evaluation of patients in the ward, among those
whose blood glucose remained higher than 180 mg/dl,
23.3% needed to be transferred to the ICU due to illness
complications, compared to 4.5% of those whose glucose
levels remained normal (p = 0.0001). The mortality rate
in patients with hyperglycemia in the ICU was 16.1%,
compared to 2.8% (p = 0.0001) among patients with nor-
mal glucose levels.
Although concurrent illness and medication changes
may cause hyperglycemia during hospitalization, the low
number of patients assessed for blood glucose made it
impossible to assess the effects of hyperglycemia in a
multivariate adjustment for all-cause mortality and illness
complications associated with hyperglycemia.
Other investigators have previously found that even
admission and persistent hyperglycemia events are asso-
ciated with adverse outcomes and increased mortality
after multivariate adjustment [13,19,23].
However, improved control has been shown to reduce
mortality in several populations [7,8,28,29].
In this study, severe hypoglycemia, a complication that
partially drives the undertreatment of hyperglycemia, was
not as frequent as hyperglycemia. Hypoglycemia
occurred in 7.2% of the patients in the ward and 24% in
the ICU; hypoglycemia is avoidable with appropriate
management.
Since the early 1990 s, it has been known [24,25] that
the use of sliding-scale insulin in the absence of basal
insulin is associated with wide glycemic variations. Con-
sensus guidelines [4] and individual experts [26] suggest
that optimal management of inpatient glycemia should
include basal insulin with prandial insulin coverage rather
than sliding scales alone.
Table 2: Length of hospital stay for different patient groups
Glucose levels and diagnosis (groups) Average length of hospitalizations (days) Average number of hospitalizations
Group (1) 6.3 1.5
Group (2) 8.7 1.5
Group (3) 10.1 1.6
Group (4) 15.5 1.5
Group (5) 6.3 1.3
Group(1) = DM+ Normal Glucose; Group(2) = DM+ Hyperglycemia; Group(3) = Hospital Hyperglycemia; Group(4) = Persistent Hyperglycemia; 
Group(5) = Normal Glycemia
Table 3: Mortality in patients with normal and abnormal glucose levels: Ward patients vs. ICU patients
Ward Patients ICU Patients
Glucose Level Normal Abnormal Normal Abnormal
Number of Patients 246 249 71 149
N u m b e r  o f  D e a t h s 0422 4
Mortality Rate 0% 1.6% 2.8% 16.1%Leite et al. Diabetology & Metabolic Syndrome 2010, 2:49
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In our analysis of data from one general hospital rou-
tine, sliding scales were prescribed as the sole treatment
in 75% of the ward patients and 86% of the ICU patients,
and insulin infusion was used only in 3.8% of the patients.
Umpierrez et al. suggested that glycemic chaos (not gly-
cemic control) is still the rule for inpatient care [26].
The restraints of using insulin infusion in patients in
the ICU include a lack of inpatient diabetes management
education for the hospital staff in addition to the absence
of a treatment algorithm suited for the real-life hospital
setting in Brazil.
Another limitation of our study was that we were not
able to determine the percentage of patients with latent
or unrecognized diabetes because of the lack of hemoglo-
bin A1C testing. The prevalence of elevated hemoglobin
A1C among patients admitted to the hospital without a
diagnosis of diabetes was high [27]. Green et al. showed
in a prospective cohort analysis of patients with diabetes
and acute coronary syndrome that almost a third of the
patients did not have an HbA1C value checked by the
time of discharge.
Management of hyperglycemia in the hospital setting
includes the measurement of HbA1C [20], and newly
diagnosed inpatients represent an opportunity to insti-
tute a plan for long-term glycemic control. If initiated
early, such intervention may lead to the prevention of
complications [30].
Unfortunately, patients with newly noted hyperglyce-
mia and established diabetes are frequently ignored in the
hospital [4].
Finally, because of data limitations, this study was
unable to test the hypothesis that hyperglycemia was the
cause for the worst outcomes in patients hospitalized.
Prior studies showed that hyperglycemic patients had
higher in-hospital mortality and morbidity rates than
those with normal glucose levels [1,4,7,14,15].
This analysis of a general hospital in Brazil revealed
persistent shortcomings in inpatient hyperglycemia man-
agement. Inpatient diabetes care delivery may require
systematic changes to meet current standards.
Conclusions
In conclusion, we observed that hyperglycemia is com-
mon in a hospital setting and is associated with increased
mortality and morbidity and longer length of hospital
stay. Thus, it is necessary to review the in-hospital man-
agement of hyperglycemia by establishing an adequate
protocol and continuous education and training within
the hospital setting for providers, nurses, and ancillary
staff.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
SAOL participated in the design of the study, write the manuscript and is the
Senior of the project. SBL participated in the design of the study and partici-
pated in the collect data, SPN participated in the collect data, ARFO partici-
pated in the design of the study and participated in the collect data, DT
participated in the design of the study and participated in the collect data, TT
participated in the design of the study and participated in the collect data. All
authors read and approved the final manuscript.
Acknowledgements
We are grateful to the team at the Hospital Cruz Vermelha Brasileira - Filial do 
Paraná and statistician Paulo R B Guimarães for their collaboration.
This study was made possible by a research grants from the Sanofi-Aventis.
Author Details
1Internal Medicine of Universidade Positivo, Curitiba, PR, Brasil and 
2Universidade Positivo, Curitiba, PR, Brasil
References
1. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE: 
Hyperglycemia: An Independent Marker of In-Hospital Mortality in 
Patients with Undiagnosed Diabetes.  The Journal of Clinical 
Endocrinology & Metabolism 2002, 87(Suppl 3):978-982.
2. Vanhorebeek I, Langouche L, Berghe GVD: Intensive Insulin Therapy in 
the Intensive Care Unit: Update on Clinical Impact and Mechanisms of 
Action.  Endocrine Practice 2006, 12(Suppl 3):14-22.
3. Kitabchi AE, Freire AX, Umpierrez GE: Evidence for strict inpatient 
glycemic control: time to revise glycemic goals in hospitalized 
patients.  Metabolism Clinical and Experimental 2008, 57:116-120.
4. ACE/ADA Task Force on Inpatient Diabetes: American College of 
Endocrinology and American Diabetes Association Consensus 
Statement on Inpatient Diabetes and Glycemic Control.  Endocrine 
Practice 2006, 12(Suppl 4):458-468.
5. Thompson CL, Dunn KC, Menon MC, Kearns LE, Braithwaite SB: 
Hyperglycemia in the Hospital.  Diabetes Spectrum 2005, 18(Suppl 
1):20-27.
6. Yendamuri S, Fulda GJ, Tinkoff GH: Admission Hyperglycemia as a 
Prognostic Indicator in Trauma.  The Journal of Trauma 2003, 55(Suppl 
1):.
7. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz 
M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive Insulin 
Therapy in Critically Ill Patients.  N Engl J Med 2001, 345(Suppl 
19):1359-1367.
8. Van den Berghe G, Wilmer A, Hermans G, et al.: Intensive insulin therapy 
in the medical ICU.  N Engl J Med 2006, 354:449-461.
9. Brunkhorst FM, Engel C, Bloos F, et al.: Intensive insulin therapy and 
pentastarch resuscitation in severe sepsis.  N Engl J Med 2008, 
358:125-139.
10. American Society of Health-System Pharmacists: Improving glycemic 
control in hospital patients with and without diabetes mellitus.  Am J 
Health-Syst Pharm 2007, 64(Suppl 6):21-23.
11. The NICE-SUGAR Study Investigator: Intensive versus Conventional 
Glucose Control in Critically Ill Patients.  N Engl J Med 2009, 
360(13):1283-1297.
12. Clement S, Braithwaite SS, Magee MF, Ahmann A, Simith EP, Schafer RG, 
Hirsh IB: American Diabetes Association Diabetes in Hospitals Writing 
Committee: Management of diabetes and hyperglycemia in hospitals 
(Technical Review).  Diabetes Care 2004, 27:553-597.
13. Lansang MC, Umpierrez GE: Management of Inpatient Hyperglycemia in 
Noncritically Ill Patients.  Diabetes Spectrum 2008, 21(Suppl 4):248-255.
14. Wexler DJ, Meigs JB, Cagliero E, Nathan DM, Grant RW: Prevalence of 
Hyper- and Hypoglycemia Among Inpatients With Diabetes.  Diabetes 
Care 2007, 30(Suppl 2):367-369.
15. Wilson M, Weinreb J, Hoo GWS: Intensive Insulin Therapy in Critical Care.  
Diabetes Care 2007, 30:1005-1011.
16. Moghissi ES, et al.: AACE/ADA Inpatient Glycemic Control Consensus 
Panel.  Endocr Pract 2009, 15(4): [http://www.aace.com/pub/pdf/
guidelines/InpatientGlycemicControlConsensusStatement.pdf].
Received: 9 March 2010 Accepted: 21 July 2010 
Published: 21 July 2010
This article is available from: http://www.dmsjournal.com/content/2/1/49 © 2010 Leite et al; licensee BioMed Central Ltd.  This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Diabetology & Metabolic Syndrome 2010, 2:49Leite et al. Diabetology & Metabolic Syndrome 2010, 2:49
http://www.dmsjournal.com/content/2/1/49
Page 6 of 6
17. Devos P, Preiser JC, Melot C: Impact of tight glucose control by intensive 
insulin therapy on ICU mortality and the rate of hypoglycaemia: final 
results of the glucontrol study.  Intensive Care Med 2007, 33(Suppl 
2):S189.
18. Tomky D: Detection, Prevention and Treatment of Hypoglycemia in the 
Hospital.  Diabetes Spectrum 2005, 18(Suppl 1):39-44.
19. Green Conaway DL, Enriquez JR, Barberena JE, et al.: Assessment of and 
physician response to glycemic control in diabetic patients presenting 
with an acute coronary syndrome.  Am Heart J 2006, 152(6):1022-1027.
20. Inzucchi SE: Management of Hyperglycemia in the Hospital Setting.  N 
Engl J Med 2006, 355:1903-11.
21. Conner TM, Flesner-Gurley KR, Barner JC: Hyperglycemia in the Hospital 
Setting: The Case for Improved Control Among Non-Diabetics.  Ann 
Pharmacother 2005, 39(Suppl 3):492-501.
22. Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, 
Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE: American 
Association of Clinical Endocrinologists and American Diabetes 
Association Consensus Statement on Inpatient Glycemic Control.  
Diabetes Care 2009, 32:1119-1131.
23. Kosiborod M, Inzucchi SE, Krumholz HM, Xiao L, Jones PG, Fiske S, Masoudi 
FA, Marso SP, Spertus JA: Glucometrics in Patients Hospitalized With 
Acute Myocardial Infarction: Defining the Optimal Outcomes-Based 
Measure of Risk.  Circulation 2008, 117:1018-1027.
24. Gearhart JG, Duncan J, Replogle WH, Forbes RC, Walley EJ: Efficacy of 
sliding-scale insulin therapy: a comparison with prospective regimens.  
Fam Pract Res J 1994, 14:313-322.
25. Queale WS, Seidler AJ, Brancati FL: Glycemic control and sliding scale 
insulin use in medical inpatients with diabetes mellitus.  Arch Intern 
Med 1997, 157:545-552.
26. Umpierrez GE, Maynard G: Glycemic chaos (not glycemic control) still 
the rule for inpatient care: how do we stop the insanity?  J Hosp Med 
2006, 1:141-144.
27. Wexler DJ, Nathan DM, Grant RW, Regan S, Van Leuvan AL, Cagliero E: 
Prevalence of Elevated Hemoglobin A1c among Patients Admitted to 
the Hospital without a Diagnosis of Diabetes.  J Clin Endocrinol Metab 
2008, 93:4238-4244.
28. Malmberg K, DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute 
Myocardial Infarction) Study Group: Prospective randomised study of 
intensive insulin treatment on long term survival after acute 
myocardial infarction in patients with diabetes mellitus.  BMJ 1997, 
314(7093):1512-1515.
29. Malmberg K, Ryde'n L, Wedel H, DIGAMI 2 Investigators, et al.: Intense 
metabolic control by means of insulin in patients with diabetes 
mellitus and acute myocardial infarction (DIGAMI 2): effects on 
mortality and morbidity.  Eur Heart J 2005, 26(7):650-661.
30. Leite SAO, Anderson RL, Kendall DM, Monk AM, Bergenstal RM: A1C 
predicts type 2 diabetes and impaired glucose tolerance in a 
population at risk: the community diabetes prevention project.  
Diabetology & Metabolic Syndrome 2009, 1(5):1-7.
doi: 10.1186/1758-5996-2-49
Cite this article as: Leite et al., Impact of hyperglycemia on morbidity and 
mortality, length of hospitalization and rates of re-hospitalization in a general 
hospital setting in Brazil Diabetology & Metabolic Syndrome 2010, 2:49